Hong Zong
Overview
Explore the profile of Hong Zong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
851
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zong H, Zhang L, Cheng Y, Sheng Z, Zhuge B, Lu X
ACS Synth Biol
. 2025 Jan;
14(1):273-284.
PMID: 39757760
DegSU quorum sensing (QS) system enables autoinducible expression of recombinant proteins in . However, insufficient promoter strength and a complex regulatory circuit limit its practical application. Here, the QS-responsive promoter...
2.
Lu X, Hao X, Lv W, Zhuge B, Zong H
Biotechnol J
. 2024 Oct;
19(10):e202400397.
PMID: 39380498
The hydrolysis of cellulose generates inhibitors like acetate, suppressing fermentation performance. Here, 25SrRNA methyltransferase CgBMT5 from stress-tolerant yeast Candida glycerinogenes was used as an anti-stress gene element in Saccharomyces cerevisiae...
3.
Meng X, Wang J, Xia J, Wu T, Luo Z, Hong Y, et al.
Eur J Cancer
. 2024 Sep;
212:114328.
PMID: 39307038
Background: With the increasing use of immune checkpoint inhibitors (ICIs) in advanced esophageal squamous cell carcinoma (ESCC), there remains an unmet need for options to address disease progression after prior...
4.
Zhang R, Su C, Jia Y, Xing M, Jin S, Zong H
Biomed Pharmacother
. 2024 Sep;
179:117363.
PMID: 39236476
HER2 amplification is one of the mechanisms that induce drug resistance to anti-EGFR therapy in colorectal cancer. In recent years, data from several randomized clinical trials show that anti-HER2 therapies...
5.
Zhao X, Zong H, Lu X, Zhuge B
Biotechnol Lett
. 2024 Jul;
46(6):1057-1068.
PMID: 39085486
Objectives: Toxicants inhibit microbial fermentation and reduce product titres. This work investigated the glycerol production characteristics of Candida glycerinogenes in highly toxic unwashed undetoxified hydrolysate and provided new ideas for...
6.
An T, Qiu H, Zhou Q, Zong H, Hu S, Lian Y, et al.
World J Gastrointest Oncol
. 2024 Jul;
16(6):2449-2462.
PMID: 38994132
Background: Regorafenib (R) and fruquintinib (F) are the standard third-line regimens for colorectal cancer (CRC) according to the National Comprehensive Cancer Network guidelines, but both have limited efficacy. Several phase...
7.
Zheng J, Li Y, Lu X, Zhuge B, Zong H
Food Sci Biotechnol
. 2024 May;
33(8):1899-1908.
PMID: 38752109
M5 and Goji Berry extract were co-microencapsulated to maintain the activity of cells during gastrointestinal digestion, and the mechanism by which they could maintain high activity was investigated. The results...
8.
Wang M, Jiang D, Lu X, Zong H, Zhuge B
ACS Synth Biol
. 2024 May;
13(6):1716-1726.
PMID: 38733342
NAD is a redox coenzyme and is the center of energy metabolism. In metabolic engineering modifications, an insufficient NAD(H) supply often limits the accumulation of target products. In this study,...
9.
Wang J, Lu X, Zhuge B, Zong H
J Sci Food Agric
. 2024 Apr;
104(12):7375-7385.
PMID: 38666395
Background: Carboxypeptidase is an exopeptidase that hydrolyzes amino acids at the C-terminal end of the peptide chain and has a wide range of applications in food. However, in industrial applications,...
10.
Wang X, Zhao C, Lu X, Zong H, Zhuge B
Front Microbiol
. 2024 Apr;
15:1379688.
PMID: 38567071
Caffeic acid (CA) is a phenolic acid compound widely used in pharmaceutical and food applications. However, the efficient synthesis of CA is usually limited by the resources of individual microbial...